• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Debio 1143 and High-Dose Cisplatin Chemoradiotherapy in High-Risk Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: A Double-Blind, Multicentre, Randomised, Phase 2 Study

home / publications / supplement / debio-1143-and-high-dose-cisplatin-chemoradiotherapy-in-high-risk-locoregionally-advanced-squamo
© 2024 MJH Life Sciences
AJMC®
All rights reserved.